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Abstract. In this paper the option value of waiting under scientific 
uncertainty will be derived using the difference between the geometric 
Brownian motion and the mean reverting process by applying contingent 
claim analysis. The results will be compared with those generated by 
either using a geometric Brownian motion or a mean-reverting process 
only. An example based on the decision problem whether or not to release 
herbicide tolerant rape seed in the EU will be used to illustrate the 
differences. The paper contributes to the suggestion made by biologists to 
further analyze the sensitivity of the results using the real option approach, 
provides insights about the magnitude of error that can be made by 
choosing the wrong process, provides a solution to the problem and 
highlights the implication for the decision of whether or not to release 
transgenic crops. The results show that scientific uncertainty is less 
important than one would expect at first hand. 
 
Keywords: biotechnology, cost-benefit analysis, real option, scientific 
 uncertainty. 
JEL: Q, D81, D61. 
 
 




Economists have proposed the real option theory for the ex-ante valuation of costs and 
benefits from transgenic crops. Farrow, Morel, Wu and Casman (2001) in their paper 
model the uncertain incremental net-benefits from transgenic crops by using a 
geometric Brownian motion process
1. The build up of pest resistance is included by 
adding a jump process describing the decay of resistance. Irreversibilities, I, are 
explained by possible gene drifts from transgenic crops. Wesseler and Weichert 
(1999) and Wesseler (2002) used almost the same approach. Wesseler (ibid.) included 
in the later paper the possibility of irreversible benefits, R. Irreversible benefits were 
defined as the reduction of irreversible costs of the alternative technology. Gilligan 
(2002) in a review of Farrow et al. (ibid.) and Wesseler (ibid.) argued that further 
discussion on the sensitivity of the results is needed in a dialogue with biologists. One 
assumption made in both papers is that resistance is inevitable. This does not 
necessarily have to be the case. As Gilligan (ibid.) clearly pointed out gene drift may 
lead to invasion but invasion may not lead to persistence and pest resistance may 
occur but may also break down again over time. That is to say that there is not only 
uncertainty about the economic variables but also uncertainty about the biological 
processes. This adds uncertainty to the models used by Farrow et al. and Wesseler and 
will have two effects. On the one hand, this will lead to uncertain irreversible costs; 
on the other hand it will affect the incremental net-benefits from transgenic crops.  
                                                            
1 The incremental net-benefits are the differences between transgenic and non-transgenic crops.  Let’s ignore for a while the uncertainties about the irreversible costs by 
assuming they are constant
2, and concentrate on the incremental net-benefits. 
If the incremental net-benefits of a transgenic crop will be negatively affected 
over time due to invasion, they will decrease, if not, it can be assumed they will 
continue to grow. Both situations are not unfamiliar to economists. A geometric 
Brownian motion can model the uncertain growth as has been done by Farrow et al. 
(ibid.) and Wesseler (ibid.). If pest resistance occurs, the decrease over time can be 
modeled by using a mean reverting process. The problem then would be to decide 
which kind of process to use.  
A solution to the problem would be simple if by using an appropriate 
econometric method time series data could be tested to decide which process to use. 
As Dixit and Pindyck (1994) and others (e.g. Gjolberg and Guttormsen, 2002) have 
pointed out the results are ambiguous. Depending on the time frame used, the tests 
either lead to a rejection or acceptance of a non-stationary process. They recommend 
choosing the process not based on time series analysis but based on theoretical 
grounds. This is a straightforward recommendation, if scientists can agree about the 
relevant theory. But as the case for transgenic crops shows (Gilligan ibid.), there is no 
scientific certainty about the stochastic benefits from transgenic crops. Scientists are 
aware of the problem, but have no method available that tells them which model to 
choose. This is what in this context will be called scientific uncertainty.  
From a decision makers point of view this may not be important if different 
processes do not lead to different recommendations. As Wesseler (2001) has pointed 
out, the choice of a stochastic process may but not necessarily will lead to different 
recommendations. Figure 1 shows a comparison between a geometric Brownian 
                                                            
2 That this is a useful assumption has been explained by Wesseler (ibid.). motion and a mean reverting process and the decision to release transgenic crops, 
where it is assumed that each process represents a scientific belief or view about the 
benefits from transgenic crops. The situations depicted under quadrant I and quadrant 
IV lead to unequivocal decisions: either immediate release, quadrant I, or delaying the 
release, quadrant IV. On the other, hand the situations depicted in quadrant II and III 
are equivocal: depending on the stochastic processes either immediate release or 
delaying the release is economical. Specifically the situation in quadrant III is of 
importance as the geometric Brownian process dominates the mean reverting process 


























V ≤  V*GB ∧  V ≤  V*MR  
1GB: geometric Brownian motion; 
2MR: mean reverting process. 
Figure 1: Possible Combinations of Results Under Different Belief Systems 
(Wesseler, 2001). 
 
These observations lead to an important question: Do we have to choose 
between different processes or is it possible to combine the processes to also capture 
                                                            
3 For a definition of almost first degree of stochastic dominance see Anderson et al. (1989). the uncertainty about the choice of the stochastic process? This is what will be 
discussed in this paper. 
In the following, the option value of waiting under scientific uncertainty as 
illustrated in quadrant III of figure 1 will be derived using the difference between the 
geometric Brownian motion and the mean reverting process by applying contingent 
claim analysis. The results will be compared with those generated by either using a 
geometric Brownian motion or a mean-reverting process only. An example based on 
the decision problem whether or not to release herbicide tolerant rape seed in the EU 
will be used to illustrate the differences. The paper contributes to the suggestion made 
by Gilligan (ibid.) to further analyze the sensitivity of the results by Farrow et al. 
(ibid.) and Wesseler (ibid.), provides insights about the magnitude of error that can be 
made by choosing the wrong process, provides a solution to the problem and 
highlights the implication for the decision of whether or not to release transgenic 
crops. 
 
2. The Option Value Under Scientific Uncertainty 
The full value of owning the right to release a specific transgenic crop, F(B,t), 
depends on the incremental net-benefits B from releasing the transgenic crop. 
Exercising the option to release provides a benefit stream π (B,t) to the holder of the 
right
4 and produces not only irreversible costs but also irreversible benefits as 
discussed in detail in Wesseler (2002). The owner of the option, the decision maker, 
likes to know the value of the option and if to exercise immediately that is allowing 
releasing the transgenic crop for planting. Let’s also assume the decision maker likes 
to release the transgenic crops without bearing any economic risk. By replicating the uncertain returns with known values from the market will derive the riskless value of 
the option to release transgenic crops. This is one of the basic insights of real option 
theory.
5 As Fisher (2000) has demonstrated this is equivalent to the quasi-option 
approach in environmental economics by Arrow and Fisher (1974) and Henry (1974) 
and further developed by Fisher and Hanemann (1986) and Hanemann (1989). 
If it is assumed that the incremental net-benefits B of releasing transgenic crops 
follow a mean reverting process, they should be released immediately if B is greater 
than the identified hurdle rate for a mean reverting process
*
MR B . As B may also follow 
a geometric Brownian motion that dominates the mean reverting process the 
additional uncertainty of the difference between the two stochastic processes, the 
scientific uncertainty, 
*
SU B , can be added, resulting in a hurdle rate 
*






SU MR B B B ⋅ = +  (1) 
The hurdle for transgenic crops under a mean-reverting process has been 
identified and discussed already elsewhere (e.g. Wesseler, 2002). Now, the steps to 
derive the real option value under scientific uncertainty and hence the hurdle for 
scientific uncertainty will be presented. Following Dixit and Pindyck (1994, pp. 20-
21) a portfolio can be constructed that replicates the risk of releasing transgenic crops 
which consists of n units of incremental net-benefits from transgenic crops, nB, and 
one Euro invested in a riskless asset. If this portfolio will be hold over a short time 
interval, dt, the value of the portfolio will change depending on the rate of return, r, of 
the riskless asset and the change in value of nB. The change in value of nB may pay a 
dividend, δ , from holding it over the short time interval nδ Bdt and an uncertain return 
                                                                                                                                                                      
4 Think, e.g., of the EU-commission acting as the representative of EU citizens, similar to the manager 
of a private company acting on behalf of the stock owners. 
5 The seminal book by Dixit and Pindyck (1994) demonstrate the wide application possibilities of the 
real option approach. Nobel laureate Robert C. Merton (1998) provides an overview of the application ndB. dB follows a process which is the difference between a geometric Brownian 
process and a mean reverting process, where the geometric Brownian process 
dominates the mean reverting process by FSD: 
() Bdz Bdt B B Bdz ~ Bdt dB σ η σ α − − − + =  (2) 
with   B: incremental net-benefits of transgenic crops, 
  α : growth rate of incremental benefits assuming geometric Brownian motion, 
  σ ~: variance rate of the geometric Brownian motion, 
  η : speed of reversion, 
  σ : variance rate of the mean-reversion process, 
  B : reversion level, 
  dz: Wiener process 
The expected value of a percentage change in incremental net-benefits over a 
short time interval is  () B B − − η α  which is not constant as it depends on B which 
fluctuates stochastically. Therefore, as B has to provide an expected rate of return 
equal to the risk adjusted rare of return, µ , derived from the capital asset pricing 
model as otherwise it would be more economically to reallocate investments, the 
expected return of the investment has to equal  () δ η α µ + − − = B B  and hence δ  
depends on B,  () () B B B − + − = η α µ δ  (Dixit and Pindyck 1994, 147-150).  
The return per Euro invested in the whole portfolio is: 
() ()
nB 1




− − − + + +
=
+
+ σ η σ α δ σ
 












+ − − + σ σ δ η α
. (3) 
                                                                                                                                                                      
of option pricing theory outside financial economics. The book by Amram and Kulatilaka (1999) The first part of equation 3 is certain while the second part is uncertain. To 
simplify the notation we write  Bdz Bdz ~ Bdz σ σ σ − = . This portfolio can be compared 
with planting transgenic crops instead of buying them. Planting transgenic crops 
means exercising the option and hence, costs F(B,t). Exercising the option provides 
immediate incremental net-benefits π (B,t)dt. At the time of release this benefits are 
known with certainty over the short time interval dt. Also, the value of the option to 
release transgenic crops changes over the time interval dt. This random change can be 
calculated by applying Ito’s Lemma:  
() () dz BF dt F B
2
1
BF B B F dF B BB
2 2
B t σ σ η α + 


 + − − + = . 


























As the portfolio should replicate the risk of releasing transgenic crops, the 
uncertain part of the portfolio has to be equal to the uncertain part of the returns from 










The arbitrage pricing principle says that two assets in the market with the same 
risk have to have the same value. If the same line of thinking will be applied, than also 
the certain return of the portfolio and the certain return from the release of transgenic 
crops have to be the same: 






BF B B F
dt
nB 1
B B B n r BB
2 2
B t σ η α π δ η α + − − + +
=
+
+ − − +
. (6) 
                                                                                                                                                                      
includes several case studies of real option pricing. If nB/(1+nB) is substituted on the right-hand side by  dz
F
BFB  from equation 4 and δ  
substituted by  () B B − + − η α µ , equation 5 can be rearranged to provide: 




2 2 = + − − − + − + π η α µ σ . (7) 
The term Ft dropped as an infinite stream of returns from transgenic crops is assumed 
if once released. The boundary conditions for the differential equation 7 are the well-
known ‘value matching’ (equation 9) and the ‘smooth pasting’ (equation 10) 
conditions and that the value of the option to release transgenic crops has no value if 
there are no incremental net-benefits (equation 8): 
0 ) 0 ( F =  (8) 
R I * B *) B ( F + − =  (9) 
* B *) B ( F ′ = ′ . (10) 
A solution to the differential equation 7 and hence, the value of the option, can be 
found by defining a function of the form: 
() () B h AB B F
θ = , (11) 
where A and θ  are constants that have to be chosen to solve equation 7. Following the 
steps provided by Dixit and Pindyck (1994, 162-163), first equation 11 will be 
substituted in equation 6. After rearrangement: 
() ()
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+ ηθ η η α µ θ σ σ




Second, the terms in brackets both have to be equal to zero. The first bracketed term is 
a quadratic equation. As one of the boundary conditions is F(0) = 0, only the positive solutions will be considered. Solving the quadratic equation provides the following 
























+ =  (13) 
Third, the second bracketed term can be transformed into a hypergeometric 


























() 0 g g x b xg x xx = − − + θ  (14) 
where  
()
2 B r 2 2 b σ η α µ θ − + − + =  
Fourth, the solution to equation 14 is the confluent hypergeometric function 









= b , ;
B 2
H AB B F
2 θ
σ
η θ  (15) 
The values for A and the critical value B* where the release could be justified can be 
found numerically using the two remaining boundary conditions F(B*) = B*-I+R and 
FB(B) = 1. 
 
3. Application of the model 
The growth rate α  and the variance rate σ ~ were estimated by computing the 
maximum likelihood estimator assuming continuous growth (Campbell et al., 1997, 
                                                            
6 Note the difference to the result provided by Dixit and Pindyck for a mean-reverting process, where x 
is positive. Chapter 9.3). The estimators for α  and σ ~ in closed form for annual returns, g, over t 

















1 ˆ α  (16) 






1 t t a ˆ g g ln
n
1 ˆ ~ σ  (17) 
The estimators for the mean reverting process are  ( ) , b ˆ 1 ln ˆ , b ˆ a ˆ g ˆ + − = − = η  and 
()
() 1 b ˆ 1




= ε σ σ , where a ˆ  and b ˆ  are estimators of the linear regression 
() t 1 t 1 t t g b a g g ln ε + + = − −  and  ε σ ˆ  is the standard error of the regression. a and b 
are substitutes for  
  ()
η − − = e 1 g a  (18) 
  () 1 t g 1 e b −
− − =
η  (19) 
of a first order autoregressive process (AR(1)) with a normally distributed error term 









− − = . 
The same estimators can be used for the parameters of the combined process of 
equation 1. dB can be decomposed in dB = dBBM - dBMR.. 
The parameters to calculate the different hurdle rates will be estimated from 
FAO time series data for rape seed in France. Rape seed was chosen as herbicide 
tolerant seed varieties exist that show a high adoption rate in the United States and can 
be expected to be technically suitable for France as well where rape seed is grown on 
a large scale. The average return per hectare for rape seed in France over the period 
1970 to 1995 are provided by FAO (2002). As the FAO statistics provide only 
nominal prices, the data were transferred into real prices in US dollar (USD) using the United States Department of Agriculture (Shane, 2000) real exchange rates for rape 
seed. The data to estimate the mean-reverting process have been scaled down by 
dividing the annual gross revenue from rape seed by the estimated long-run average 
level, which was estimated to be about 5510 USD per hectare. These data have been 
used for the estimation of the parameter values shown in table 1 and table 2. 
In addition to the estimated parameter values the risk free interest rate, r, is 
assumed to be about 4.5%, which is equivalent to the interest rate at the European 
Central Bank for the month of December 2000. The risk adjusted rate of return µ  is 
assumed to be 8%. For simplicity it is also assumed that the net irreversible costs  
I – R = 1. 
In the case of rape seed the immediate incremental net-benefits are about 32% if 
the results from Canada are applied to the EU (Serecon Management Consulting Inc. 
and Koch Paul Associates, 2001, Table 4.4). In this case modeling incremental net-
benefits B by a mean reversion process would result in a hurdle rate of 
*
MR B =  1.296 
and passed by B = 1.32. The value of scientific uncertainty with 1.009 is low and 
increases the hurdle rate to about 
*
SU MR B +  = 1.308, which will also be passed by B. If a 
geometric Brownian motion would be assumed the hurdle rate would be 
*
GB B  = 2.43 
and not be passed. Ignoring the scientific uncertainty about the underlying stochastic 
process would in this case result in the wrong decision to not release transgenic crops, 
if a geometric Brownian motion would be assumed. Table 1. Parameter estimations for the geometric Brownian motion and the 
mean reverting process. 
Geometric Brownian motion  Mean reverting process 
α ˆ  = 0.0473  a ˆ = 0.2635 
σ ˆ ~ = 0.2871  b ˆ = -0.2635 
 
ε σ ˆ = 0.2728 
  ηˆ = 0.3059 
  σ ˆ = 0.1824 
 
 
Table 2. Parameter values chosen for the calculation of immediate minimum benefits 
B* 
Parameter (annual)  Value  Source 
growth rate α ˆ   0.047 FAO  (2002) 
risk-free rate of return r  0.045  European Central Bank, Dec. 2000 
standard deviation σ ˆ ~  0.287 FAO  (2002) 
risk adjusted rate of return, µ   0.080 assumed 
convenience yield, δ   0.033  (µ -α ˆ ) 
β  1.453 equation  (9) 
β/(β−1)  3.207  
2.429  geometric Brownian motion 
1.296  mean reverting process 
1.009 scientific  uncertainty 
B*  
assuming I – R = 1 
1.308  including scientific uncertainty 
 4. Conclusion 
In this paper we have addressed the problem of scientific uncertainty defined as the 
problem of identifying the correct stochastic process of incremental net-benefits from 
transgenic crops. Combining a mean reversion and geometric Brownian process 
reduced the problem of scientific uncertainty. An application of the approach to the 
release of rape seed indicated only a small impact of scientific uncertainty. Ignoring 
scientific uncertainty on the other hand may lead to a wrong decision. It still has to be 




I am grateful to Chris Gilligan and João Filipe of the Department of Plant Sciences, 
University of Cambridge and their colleagues for the fruitful discussions on 
epidemiological and economic aspects of transgenic crops. This research was 
supported by the King’s College Research Center at Cambridge and by a travel grant 




Amram, M. and N. Kulatilaka. 1999. Real Options. Boston, MA: Harvard Business 
School Press. 
Anderson, J. R., C. J. Findlay and G. H. Wan. 1989. Are modern cultivars more risky? 
A question of stochastic efficiency. In Jock R. Anderson and Perter B. Hazell 
(eds.) Variability in Grain Yields. Baltimore, USA: John Hopkins University 
Press. 
Arrow, K.J. and A. C. Fisher. 1974. Environmental Preservation, Uncertainty, and 
Irreversibility. Quarterly Journal of Economics 88: 312-319. 
Campbell, J.Y., Lo, A.W. and MacKinlay, A.C. (1997). The Econometrics of 
Financial Markets. Princeton: Princeton University Press. Dixit, A. K. and R. S. Pindyck. 1994. Investment Under Uncertainty. Princeton: 
Princeton University Press. 
FAO 2002. Statistical Database. <http://apps.faor.org/cgi-bin/nph-db.pl> (20 March 
2002). 
Farrow, S., B. Morel, F. Wu, and E. Casman. 2001. Pesticide Resistance, the 
Precautionary Principle, and the Regulation of Bt Corn: Real and Rational 
Option Approaches to Decision-Making. Resources for the Future Conference 
on “Economics of Resistance”, April 5-6, 2001, Airlie House, Virginia. 
Fisher, A. C. 2000. Investment Under Uncertainty and Option Value in Environmental 
Economics. Resource and Energy Economics 22 (3): 197 – 204. 
--- and W. M. Hanemann. 1986. Option Value and the Extinction of Species. In V.K. 
Smith (ed.) Advances in Applied Micro – Economics. Greenwich, UK: JAI 
Press. 
Gilligan, C. A. 2002. Economics of Transgenic Crops and Pest Resistance: An 
Epidemiological Perspective. In R. Laxminarayan (ed.) Economics of 
Resistance. Washington, D.C.: Resources for the Future. 
Gjolberg, O. and Guttormsen, A.G. 2002. Real options in the forest: what if prices are 
mean-reverting? Forest Policy and Economics 4:13-20. 
Hanemann, W. M. 1989. Information and the Concept of Option Value. Journal of 
Environmental Economics and Management 16: 23-37.  
Henry, C. 1974. Investment Decision under Uncertainty: The Irreversibility Effect. 
American Economic Review 64:1006-1012. 
Merton, R. C. 1998. Application of Option Pricing Theory: Twenty-Five Years Later. 
American Economic Review 88 (3):323-349. 
Serecon Management Consulting Inc. and Koch Paul Associates. 2001. An 
Agronomic and Economic Assessment of Transgenic Canola. Canola Council of 
Canada <http://www.canola-council.org> (20 March 2002). 
Shane, M. 2000. Annual Nominal and Real Exchange Rates (1995=100) for 79 
Countries Important to U.S. Agriculture. Economic Research Service, United 
States Department of Agriculture (USDA): Washington D.C. 
<http://usda.mannlib.cornell.edu/data-sets/international/88021/ axrates.wk1> 
Wesseler, J. 2002. Resistance Economics of Transgenic Crops. A Real Option 
Approach. In R. Laxminarayan (ed.) Economics of Resistance. Washington, 
D.C.: Resources for the Future. 
---. 2001. Assessing the Risk of Transgenic Crops – The Role of Scientific Belief 
Systems.  In M. Matthies, H. Malchow, and J. Kriz (eds.) Integrative Systems 
Approaches to Natural and Social Sciences - Systems Science 2000, 319-327. Berlin: 
Springer-Verlag. 
--- and M. Weichert. 1999. Der Wert zusätzlicher Informationen bei 
Investitionsentscheidungen mit einem hohen Grad an Irreversibilität. Schriften 
der Gesellschaft für Wirtschafts- und Sozialwissenschaften des Landbaus e.V., 
Band 35, S. 293-301. Münster-Hiltrup: Landwirtschaftsverlag. 
 